Title
Category
Credits
Event date
Cost
Advancements in Pediatric Oncology: Genetic Testing and Targeted Therapies
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This session will provide participants with an in-depth understanding of the role of genetic testing in pediatric oncology, focusing on the use of germline and tumor genetic testing in diagnosing and treating pediatric cancers. It will explore the development and application of rare-disease specific drugs as models for targeted therapy and analyze the differences and similarities in cancer development between pediatric and adult patients, highlighting the implications for treatment strategies. Participants will also develop strategies for incorporating genetic testing and targeted therapies into routine clinical practice.

Pages